Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the acquisition and launch1 of Acetylcysteine Injection, 6 gm/30 mL ...

Glenmark Pharmaceuticals Ltd is quoting at Rs 1380.8, up 3.49% on the day as on 12:49 IST on the NSE. The stock is up 49.05% in last one year as compared to a 0.46% fall in NIFTY and a 4.57% fall in ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch1 of Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) ...

Mahindra & Mahindra is working to scale up some of its smaller businesses to match its portfolio of multiple large companies, ...

The recall affects around 14.76 lakh bottles of Atomoxetine Capsules in various strengths, produced by Glenmark ...

Glenmark Pharma, an India-based drug manufacturer that has been the focal point of a spate of recalls in recent years, has ...

Glenmark’s Acetylcysteine Injection (DEL) is approved based on the safety and efficacy derived from the reference drug ...

Glenmark Pharmaceuticals has launched injection Acetylcysteine in the US after acquiring its abbreviated new drug application ...

Glenmark Pharmaceuticals Inc. USA has acquired and launched Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose ...

Glenmark Pharmaceuticals Ltd. (BSE: 532296) (NSE: GLENMARK) is a research–led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on ...

Glenmark Pharmaceuticals added 1.06% to Rs 1292.35 after the US-based subsidiary, Glenmark Pharmaceuticals Inc., USA announced the acquisition and launched of Acetylcysteine Injection, single-dose ...

This new product will be available in the strength of 6 gm/30 mL (200 mg/mL) single-dose vials in the US market, marking an ...